Stock 688293 SHANGHAI OPM BIOSCIENCES CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Shanghai OPM Biosciences Co., Ltd.

Equities

688293

CNE100005PF1

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 23:00:00 16/05/2024 BST 		5-day change 1st Jan Change
36.78 CNY +1.88% Intraday chart for Shanghai OPM Biosciences Co., Ltd. -2.05% -33.33%
05-09 OPM Biosciences' Shareholder to Cut Stake MT
04-29 Shanghai OPM Biosciences Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Business Summary

Shanghai Aopu Biotechnology Co Ltd is a China-based company mainly provides cell culture medium products and services. The Company's cell culture medium products are widely used in the manufacturing of protein, antibiotics, vaccine, cell therapy products, gene therapy products, and other biological products. The Company's contract development and manufacturing organization (CDMO) service platform provides comprehensive services covering antibody engineering humanized screening, cell strain cultivation, process development, pilot scale production, and clinical-stage sample production. The Company conducts businesses both in the domestic market and overseas markets.

Number of employees: 261

Sales per Business

CNY in Million2022Weight2023Weight Delta
CHO Medium
54.9 %
150 51.0 % 133 54.9 % -11.11%
Services
29.1 %
91 30.9 % 71 29.1 % -22.17%
293 Medium
9.3 %
41 13.9 % 23 9.3 % -44.94%
Other Products
6.6 %
12 4.2 % 16 6.6 % +29.78%
Other Business
0.2 %
0 0.0 % 0 0.2 % +337.06%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
84.0 %
243 82.5 % 204 84.0 % -16.02%
Overseas
16.0 %
51 17.5 % 39 16.0 % -24.67%

Managers

Managers TitleAgeSince
Zhi Hua Xiao CEO
 Chief Executive Officer 50 26/11/13
Liang Ping Ni DFI
 Director of Finance/CFO 40 30/04/19
Chuan Yang Guo BRD
 Director/Board Member 36 31/07/14
Yun Fen He BRD
 Director/Board Member 45 30/06/16
Xiao Han Ma IRC
 Investor Relations Contact - -

Members of the board

Members of the board TitleAgeSince
Jiang Feng Li BRD
 Director/Board Member 47 11/08/20
Zhi Hua Xiao CEO
 Chief Executive Officer 50 26/11/13
Jun Jie Zhang BRD
 Director/Board Member 47 13/10/20
Yuan Xing Zhang BRD
 Director/Board Member 70 30/09/20
Yun Fen He BRD
 Director/Board Member 45 30/06/16
Liang Ping Ni DFI
 Director of Finance/CFO 40 30/04/19
Xiao Mei Li BRD
 Director/Board Member 39 30/09/20
Hua An Tao BRD
 Director/Board Member 62 30/09/20
Qian Qian Liang CHM
 Chairman 37 31/08/14
Chuan Yang Guo BRD
 Director/Board Member 36 31/07/14

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 114,772,460 29,314,896 ( 25.54 %) 242,683 ( 0.2114 %) 25.54 %

Shareholders

NameEquities%Valuation
Beijing Panmao Investment Management Co. Ltd.
15.92 %
12,023,694 15.92 % 63 M ¥
China Renaissance Partners
15.63 %
11,804,542 15.63 % 62 M ¥
China Life Private Equity Investment Co. Ltd.
12.02 %
9,079,409 12.02 % 47 M ¥
Shenzhen Fortune Caizhi Venture Capital Management Co., Ltd.
7.600 %
5,738,563 7.600 % 30 M ¥
Feng Wang
3.861 %
2,914,964 3.861 % 15 M ¥
China Merchants Fund Management Co., Ltd.
3.054 %
2,305,766 3.054 % 12 M ¥
Beijing Sanyi Investment Management Co. Ltd.
2.848 %
2,150,401 2.848 % 11 M ¥
GF Fund Management Co., Ltd.
2.032 %
1,534,279 2.032 % 8 M ¥
Huashang Fund Management Co., Ltd.
1.775 %
1,340,281 1.775 % 7 M ¥
Shanghai Wenao Management LP
1.663 %
1,255,648 1.663 % 7 M ¥
NameEquities%Valuation
Zhi Hua Xiao
72.22 %
28,043,369 72.22 % 146 M ¥
Yun Fen He
20.93 %
8,126,077 20.93 % 42 M ¥
Shandong Lufa Pharmaceutical Investment Co., Ltd.
2.660 %
1,032,787 2.660 % 5 M ¥

Company contact information

Shanghai OPM Biosciences Co. Ltd.

28 Lane 908 Ziping Road

201321, Shanghai

+

http://www.opmbiosciences.com
address Shanghai OPM Biosciences Co., Ltd.(688293)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Biopharmaceuticals

Sales per Business

Sales per region

Ratings for Shanghai OPM Biosciences Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
36.78 CNY
Average target price
58.66 CNY
Spread / Average Target
+59.49%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Biopharmaceuticals

1st Jan change Capi.
SHANGHAI OPM BIOSCIENCES CO., LTD. Stock Shanghai OPM Biosciences Co., Ltd.
-33.33% 585M
CSL LIMITED Stock CSL Limited
-3.05% 90.45B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
+3.68% 41.45B
BIOGEN INC. Stock Biogen Inc.
-11.05% 33.57B
UCB Stock UCB
+60.08% 25.73B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
-19.87% 14.73B
INCYTE CORPORATION Stock Incyte Corporation
-8.92% 12.82B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-11.34% 11.7B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-43.53% 11.44B
SWEDISH ORPHAN BIOVITRUM AB Stock Swedish Orphan Biovitrum AB
+4.87% 8.79B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. 688293 Stock
  4. Company Shanghai OPM Biosciences Co., Ltd.